Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
SLXN Silexion Therapeutics Corp Ordinary Shares rises seven percent even as Q4 2025 EPS falls short of analyst expectations TAK Takeda Pharmaceutical Company Limited American Depositary Shares reports 906 percent Q1 2026 EPS beat but stock slips slightly today BGB BX Credit 27 completes fiscal quarter amid credit market shifts fund focuses on portfolio adjustments and yield optimization Is Gladstone LANDO stock building trend strength Smart Money Active 20260420 Why Yunhong YHGJ ability to innovate sets it apart Smart Money Active 20260511 What Selective SIGIP is doing to stay ahead Investor Concern 20260511 TRTNF Triton quarterly earnings release lacks published core financial results and forward guidance for investors Sachem SCCD Delivers Q4 2025 Beat EPS 003 vs 000 Expected Div Health DHC Q1 2026 Results Fall Short EPS 018 Revenue NA WisdomTree WT Q1 2026 Earnings 027 EPS Surges Past 026 Estimates What Aprea APREs 913 Decline Means for Investors 20260518 Cinemark CNK Up 156 Is There More Room to Run 20260514 TFS TFSL Stock Analysis Climbs 131 Eyes on 1629 20260518 US Consumer Prices Rise 38 in April Exceeding Expectations RBIs Rate Cut May Signal Shift in Monetary Policy Framework Nomura Suggests Rail Vikas Nigam Suzlon ONGC Among Key Companies Set to Declare Q4 Results Next Week Hanois Fine Dining Evolution Seven Restaurants Shaping Vietnams Culinary Landscape Fresh US Military Strikes Raise Uncertainties for Iran Nuclear Diplomacy USIran Tensions Snowflake Rally and Robinhood AI Tools Morning Market Roundup CWBC Q1 2026 Earnings EPS Beats Estimates by 486 Stock Rises Modestly DUOT Q1 2026 Earnings Wide EPS Miss Fails to Dampen Investor Sentiment BGSF Q1 2026 Earnings EPS Misses Estimates Stock Rises Slightly GSM Q1 2026 Earnings NarrowerthanExpected Loss Drives Positive Market Reaction Verrica Pharmaceuticals VRCA Q1 2026 Earnings EPS Misses Estimates as PreRevenue Stage Continues DFTX Q1 2026 Earnings EPS Miss as ClinicalStage Biotech Reports WiderThanExpected Loss Nuvve Holding NVVE Surges Over 17 Key Levels to Watch Microvast Holdings Warrants MVSTW Edge Higher Amid Thin Trading Key Levels at 001 Reliance Global Group EZRA Surges 47 as Stock Tests Key Resistance at 42 Beyond Meat BYND Hovers Near Key Support Amid Persistent Decline Actelis Networks Surges 449 as ASNS Holds at Key 009 Floor